Innova琀椀on Momentum 2024: The Global Top 100 Assessing Potential: Valuation and Patent Data When it comes to companies emerging as top innovators in their respective space, their role often goes beyond mere product development to become critical in the extensive network of technological advancement and market strategy. They bring expertise, develop proprietary technologies and often outmaneuver larger, less agile companies in responding to market needs. This innovative prowess makes them prime M&A targets. The 2024 roster of top innovators also includes some of these impactful companies that were targets in 2023 and early 2024. Source: LexisNexis® PatentSight+™ 100 ) ale c garithmic S Mirati Therapeutics o 10 mpact (L Juniper Networks e I Splunk titiv ompe C 1 10 100 1000 Portfolio Size (Logarithmic Scale) Figure 4: Average patent quality (Competitive Impact) versus Portfolio Size of patent owners with smaller portfolios with specialized technologies. The bubble size of the patent owners represents the portfolio strength (Patent Asset Index). The bubble trail illustrates the portfolio development between 2019 and 2023. Mirati Therapeutics, for instance, owns a very high-quality portfolio, as indicated by its position in Figure 4, and has been competitive in the oncology therapeutics arena. Their focused research and development efforts have yielded influential patents, propelling them to the forefront of technological development in cancer treatment. Developing a small, focused and high-quality patent portfolio increases their valuation and allure in the eyes of larger pharmaceutical companies looking to expand their therapeutic portfolio and accelerate their growth strategies. As expected, they were acquired by Bristol-Myers Squibb in late 2023 due to their potential to alter the competitive landscape significantly. LexisNexisIP.com 17